• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

使用切割球囊可能有助于生物可吸收血管支架在支架内狭窄中实现最佳贴壁。

Cutting balloon use may ease the optimal apposition of bioresorbable vascular scaffold in in-stent stenosis.

作者信息

Karabulut Ahmet, Demirci Yasemin

机构信息

Department of Cardiology, Faculty of Medicine, Acıbadem University, Acıbadem Atakent Hospital, Istanbul, Turkey.

出版信息

Postepy Kardiol Interwencyjnej. 2015;11(1):64-6. doi: 10.5114/pwki.2015.49190. Epub 2015 Mar 6.

DOI:10.5114/pwki.2015.49190
PMID:25848376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4372637/
Abstract

Bioresorbable vascular scaffolds (BVS) have different mechanical properties as compared to metallic stents. Therefore, the standard procedural technique to achieve appropriate deployment may differ. Utilisation of debulking techniques, including cutting balloon and directional atherectomy prior to BVS deployment, is still questionable. Herein, we discuss a case of coronary in-stent restenosis and reveal the advantage of predilatation of the lesion with cutting balloon prior to BVS deployment.

摘要

与金属支架相比，生物可吸收血管支架（BVS）具有不同的机械性能。因此，实现适当展开的标准操作技术可能有所不同。在BVS展开之前使用减容技术，包括切割球囊和定向旋切术，仍然存在疑问。在此，我们讨论一例冠状动脉支架内再狭窄病例，并揭示在BVS展开之前用切割球囊对病变进行预扩张的优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0303/4372637/012b77bedcac/PWKI-11-24638-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0303/4372637/c23c7f33e398/PWKI-11-24638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0303/4372637/db4cd25e5d23/PWKI-11-24638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0303/4372637/012b77bedcac/PWKI-11-24638-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0303/4372637/c23c7f33e398/PWKI-11-24638-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0303/4372637/db4cd25e5d23/PWKI-11-24638-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0303/4372637/012b77bedcac/PWKI-11-24638-g003.jpg

相似文献

1
Cutting balloon use may ease the optimal apposition of bioresorbable vascular scaffold in in-stent stenosis.使用切割球囊可能有助于生物可吸收血管支架在支架内狭窄中实现最佳贴壁。
Postepy Kardiol Interwencyjnej. 2015;11(1):64-6. doi: 10.5114/pwki.2015.49190. Epub 2015 Mar 6.
2
The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment.球囊扩张持续时间会影响生物可吸收血管支架置入术后冠状动脉节段的管腔直径。
BMC Cardiovasc Disord. 2015 Dec 11;15:169. doi: 10.1186/s12872-015-0163-5.
3
Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions.复杂冠状动脉病变中生物可吸收血管支架与第二代金属药物洗脱支架的真实世界经验比较
J Invasive Cardiol. 2018 Jul;30(7):251-255. Epub 2018 Apr 15.
4
The use of a scoring balloon for optimal lesion preparation prior to bioresorbable scaffold implantation: a comparison with conventional balloon predilatation.在生物可吸收支架植入前使用评分球囊进行最佳病变准备：与传统球囊预扩张的比较。
EuroIntervention. 2016 Apr 8;11(14):e1580-8. doi: 10.4244/EIJV11I14A308.
5
The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.冠状动脉分叉处的可吸收生物可吸收血管支架：来自实验室测试的观察。
JACC Cardiovasc Interv. 2014 Jan;7(1):81-8. doi: 10.1016/j.jcin.2013.07.013. Epub 2013 Dec 11.
6
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.比较生物可吸收依维莫司洗脱冠状动脉支架（修订版 1.0 和 1.1）与金属依维莫司洗脱支架的体内急性支架回缩。
Catheter Cardiovasc Interv. 2011 Jul 1;78(1):3-12. doi: 10.1002/ccd.22864. Epub 2011 Mar 16.
7
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.光学相干断层扫描评估的血管内超声最大管腔直径和依维莫司洗脱生物可吸收血管支架的恰当置入：ABSORB 队列 B 试验的子研究。
EuroIntervention. 2012 Jun 20;8(2):214-24. doi: 10.4244/EIJV8I2A35.
8
Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study.生物可吸收血管支架治疗支架内再狭窄患者：RIBS VI 研究。
JACC Cardiovasc Interv. 2017 Sep 25;10(18):1841-1851. doi: 10.1016/j.jcin.2017.06.064. Epub 2017 Aug 30.
9
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.比较依维莫司洗脱生物可吸收血管支架与金属平台冠状动脉支架的顺应性。
JACC Cardiovasc Interv. 2010 Nov;3(11):1190-8. doi: 10.1016/j.jcin.2010.07.016.
10
Bioresorbable vascular scaffolds for the treatment of coronary artery disease: what have we learned from randomized-controlled clinical trials?用于治疗冠状动脉疾病的生物可吸收血管支架：我们从随机对照临床试验中学到了什么？
Coron Artery Dis. 2017 Jan;28(1):77-89. doi: 10.1097/MCA.0000000000000414.

引用本文的文献

1
Balloon postdilatation is a mandatory step in the deployment of bioresorbable vascular scaffold.球囊后扩张是生物可吸收血管支架植入过程中的一个必要步骤。
Anatol J Cardiol. 2017 Jan;17(1):75. doi: 10.14744/AnatolJCardiol.2017.7551.
2
Patient profile and periprocedural outcomes of bioresorbable vascular scaffold implantation in comparison with drug-eluting and bare-metal stent implantation. Experience from ORPKI Polish National Registry 2014-2015.生物可吸收血管支架植入与药物洗脱支架及裸金属支架植入相比的患者资料及围手术期结果。来自2014 - 2015年波兰国家心血管介入注册中心（ORPKI）的经验。
Postepy Kardiol Interwencyjnej. 2016;12(4):321-328. doi: 10.5114/aic.2016.63632. Epub 2016 Nov 17.
3

本文引用的文献

1
Delivery of a bioresorbable vascular scaffold to complex lesions.向复杂病变部位输送生物可吸收血管支架。
Catheter Cardiovasc Interv. 2014 Nov 1;84(5):774-8. doi: 10.1002/ccd.25105. Epub 2014 Jul 30.
2
Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?光学相干断层成像术评估 ABSORB 生物可吸收血管支架置入后新生内膜的环形分布：支架能否覆盖斑块？
Atherosclerosis. 2012 Mar;221(1):106-12. doi: 10.1016/j.atherosclerosis.2011.12.008. Epub 2011 Dec 13.
3
Design principles and performance of bioresorbable polymeric vascular scaffolds.
Twelve months clinical outcome after bioresorbable vascular scaffold implantation in patients with stable angina and acute coronary syndrome. Data from the Polish National Registry.
生物可吸收血管支架植入稳定型心绞痛和急性冠状动脉综合征患者后的12个月临床结局。来自波兰国家注册中心的数据。
Postepy Kardiol Interwencyjnej. 2016;12(2):108-15. doi: 10.5114/aic.2016.59360. Epub 2016 May 11.
生物可吸收聚合物血管支架的设计原则和性能。
EuroIntervention. 2009 Dec 15;5 Suppl F:F15-22. doi: 10.4244/EIJV5IFA3.
4
Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.光学相干断层扫描评估的血管内超声最大管腔直径和依维莫司洗脱生物可吸收血管支架的恰当置入：ABSORB 队列 B 试验的子研究。
EuroIntervention. 2012 Jun 20;8(2):214-24. doi: 10.4244/EIJV8I2A35.
5
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography.新一代依维莫司洗脱生物可吸收支架光学相干断层成像术显示的对位不良和未覆盖的支架节段的序列分析。
JACC Cardiovasc Interv. 2011 Sep;4(9):992-1001. doi: 10.1016/j.jcin.2011.03.020.